)
Accendra Health (ACH) investor relations material
Accendra Health Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Operates as a nationwide provider of products, technology, and services supporting health beyond the hospital for millions annually.
Connects patients, providers, and insurers, focusing on chronic, complex, and acute health conditions.
Offers home healthcare equipment, disposable medical supplies, and integrated services across diabetes, respiratory therapy, sleep apnea, ostomy, wound care, urology, and incontinence.
Generates revenue through fee-for-service and capitation arrangements with government and commercial payors.
Utilizes technology for web portals, electronic ordering, and claims processing to improve efficiency and reduce costs.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for general corporate and working capital purposes, with temporary investment prior to use.
Risk factors and disclosures
Faces risks from competitive and pricing pressures, customer concentration, and dependence on key vendors and third parties.
Exposed to regulatory, legal, and compliance risks, including stringent healthcare regulations and potential investigations.
Subject to risks from cyberattacks, information system failures, and public health crises.
Financial condition may be impacted by contract terminations, reimbursement uncertainties, and substantial indebtedness.
Market price volatility and economic conditions may affect demand and receivables.
- Q3 revenue up 5% to $2.7B, driven by Patient Direct and $198M debt reduction.ACH
Q3 20248 Jul 2026 - All proposals passed as the company advances its home-based care strategy nationwide.ACH
AGM 202614 May 2026 - Q1 2026 revenue fell 6.8% to $627.8M, with a $1.5B balance sheet reset to boost liquidity.ACH
Q1 202611 May 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.ACH
Proxy filing2 Apr 2026 - Shareholders to vote on directors, auditor, executive pay, and expanded equity plan amid strategic transformation.ACH
Proxy filing2 Apr 2026 - 2026 guidance projects $2.55–$2.65B revenue, $335–$355M EBITDA, and strong cash flow.ACH
Q4 202519 Feb 2026 - $1.36B Rotech deal expands Patient Direct, targets $5B revenue, $50M synergies by year three.ACH
M&A Announcement3 Feb 2026 - Q2 revenue up 4–4.2% to $2.67–$2.7B; Rotech deal announced; 2024 outlook reaffirmed.ACH
Q2 20242 Feb 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and strong ESG focus.ACH
Proxy Filing1 Dec 2025
Next Accendra Health earnings date
Next Accendra Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)